{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:27:03Z","timestamp":1792218423138,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,9,12]],"date-time":"2006-09-12T00:00:00Z","timestamp":1158019200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Clin Pharmacol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1472-6904-6-5","type":"journal-article","created":{"date-parts":[[2006,9,12]],"date-time":"2006-09-12T18:21:53Z","timestamp":1158085313000},"source":"Crossref","is-referenced-by-count":37,"title":["Hemolytic uremic syndrome following the infusion of oxaliplatin: case report"],"prefix":"10.1186","volume":"6","author":[{"given":"Issa","family":"Dahabreh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tsoutsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tseligas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Janinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,12]]},"reference":[{"key":"33_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra040958","volume":"352","author":"J Meyerhardt","year":"2005","unstructured":"Meyerhardt J, Mayer R: Systemic therapy for colorectal cancer. N Engl J Med. 2005, 352: 476-487. 10.1056\/NEJMra040958.","journal-title":"N Engl J Med"},{"key":"33_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/sonc.2002.35524","volume":"29","author":"J Cassidy","year":"2002","unstructured":"Cassidy J, Misset JL: Oxaliplatin-related side effects: characteristics and management. Semin Oncol. 2002, 29: 11-20. 10.1053\/sonc.2002.35524.","journal-title":"Semin Oncol"},{"key":"33_CR3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1537-2995.2004.03111.x","volume":"44","author":"V Chen","year":"2004","unstructured":"Chen V, Thrift K, Morel-Kopp MC, Jackson D, Ward CM, Flower R: An immediate hemolytic reaction induced by repeated administration of oxaliplatin. Transfusion. 2004, 44: 838-843. 10.1111\/j.1537-2995.2004.03111.x.","journal-title":"Transfusion"},{"key":"33_CR4","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.7326\/0003-4819-139-2-200307150-00021-w3","volume":"139","author":"FG Dold","year":"2003","unstructured":"Dold FG, Mitchell EP: Sudden-onset thrombocytopenia with oxaliplatin. Ann Intern Med. 2003, 139: e156-e157.","journal-title":"Ann Intern Med"},{"key":"33_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0140-6736(99)03827-1","volume":"354","author":"J Desrame","year":"1999","unstructured":"Desrame J, Broustet H, Darodes de Tailly P, Girard D, Saissy JM: Oxaliplatin-induced haemolytic anaemia. Lancet. 1999, 354: 1179-80. 10.1016\/S0140-6736(99)03827-1.","journal-title":"Lancet"},{"key":"33_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1054\/bjoc.2000.1608","volume":"84","author":"CC Earle","year":"2001","unstructured":"Earle CC, Chen WY, Ryan DP, Mayer RJ: Oxaliplatin induced Evans' syndrome. Br J Cancer. 2001, 84: 441-441. 10.1054\/bjoc.2000.1608.","journal-title":"Br J Cancer"},{"key":"33_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1023\/A:1008336108007","volume":"11","author":"C Garufi","year":"2000","unstructured":"Garufi C, Vaglio S, Brienza S, Conti L, D' Attino RM, Girelli G, Terzoli E: Immunohemolytic anemia following oxaliplatin administration. Ann Oncol. 2000, 11: 497-497. 10.1023\/A:1008336108007.","journal-title":"Ann Oncol"},{"key":"33_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00280-003-0731-8","volume":"53","author":"RD Hofheinz","year":"2004","unstructured":"Hofheinz RD, Nguyen XD, Buchheidt D, Kerowgan M, Hehlmann R, Hochhaus A: Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient. Cancer Chemother Pharmacol. 2004, 53: 276-277. 10.1007\/s00280-003-0731-8.","journal-title":"Cancer Chemother Pharmacol"},{"key":"33_CR9","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/02841860152703553","volume":"40","author":"H Sorbye","year":"2001","unstructured":"Sorbye H, Bruserud O, Dahl O: Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis. Acta Oncol. 2001, 40: 882-883. 10.1080\/02841860152703553.","journal-title":"Acta Oncol"},{"key":"33_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1537-2995.2005.04373.x","volume":"45","author":"BM Taleghani","year":"2005","unstructured":"Taleghani BM, Fontana S, Meyer O, Ahrens N, Novac U, Borner M, Salama A: Oxaliplatin-induced immune pancytopenia. Transfusion. 2005, 45: 704-708. 10.1111\/j.1537-2995.2005.04373.x.","journal-title":"Transfusion"},{"key":"33_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000081006","volume":"67","author":"AK Koutras","year":"2004","unstructured":"Koutras AK, Makatsoris T, Paliogianni F, Kopsida G, Onyenadum A, Gogos CA, Mouzaki A, Kalofonos HP: Oxaliplatin-induced acute-onset thrombocytopenia, haemorrhage and hemolysis. Oncology. 2004, 67: 179-182. 10.1159\/000081006.","journal-title":"Oncology"},{"key":"33_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"J Moake","year":"2002","unstructured":"Moake J: Thrombotic microangiopathies. N Engl J Med. 2002, 347: 589-600. 10.1056\/NEJMra020528.","journal-title":"N Engl J Med"},{"key":"33_CR13","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1097\/01.ASN.0000060805.04118.4C","volume":"14","author":"HM Tsai","year":"2003","unstructured":"Tsai HM: Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol. 2003, 14: 1072-1081. 10.1097\/01.ASN.0000060805.04118.4C.","journal-title":"J Am Soc Nephrol"},{"key":"33_CR14","first-page":"166","volume":"72","author":"S Mayer","year":"2005","unstructured":"Mayer S, Aledort L: Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies. Mt Sinai J Med. 2005, 72: 166-175.","journal-title":"Mt Sinai J Med"},{"key":"33_CR15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V96.4.1223","volume":"96","author":"J George","year":"2000","unstructured":"George J: How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood. 2000, 96: 1223-1229.","journal-title":"Blood"},{"key":"33_CR16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/ndt\/17.7.1228","volume":"17","author":"I Tostivit","year":"2002","unstructured":"Tostivit I, Mougenot B, Flahault A, Vigneau C, Costa MA, Haymann JP, Sraer JD, Rondeau E: Adult haemolytic uraemic syndrome: causes and prognostic factors in the last decade. Nephrol Dial Transplant. 2002, 17: 1228-1234. 10.1093\/ndt\/17.7.1228.","journal-title":"Nephrol Dial Transplant"},{"key":"33_CR17","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1056\/NEJMcp053024","volume":"354","author":"JN George","year":"2006","unstructured":"George JN: Clinical practice. Thrombotic thrombocytopenic porpura. N Engl J Med. 2006, 354: 1927-1935. 10.1056\/NEJMcp053024.","journal-title":"N Engl J Med"},{"key":"33_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","volume":"8","author":"PJ Medina","year":"2001","unstructured":"Medina PJ, Sipols JM, George JN: Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2001, 8: 286-293. 10.1097\/00062752-200109000-00004.","journal-title":"Curr Opin Hematol"},{"key":"33_CR19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.1985.3.5.723","volume":"3","author":"JE Cantrell Jr","year":"1985","unstructured":"Cantrell JE, Phillips TM, Schein PS: Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol. 1985, 3: 723-734.","journal-title":"J Clin Oncol"},{"key":"33_CR20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1200\/JCO.1989.7.6.781","volume":"7","author":"JB Lesesne","year":"1989","unstructured":"Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS, Neefe JR: Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol. 1989, 7: 781-789.","journal-title":"J Clin Oncol"},{"key":"33_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1023\/A:1008263516099","volume":"8","author":"P Ross","year":"1997","unstructured":"Ross P, Norman A, Cunningham D, Webb A, Iveson T, Padhani A, Prendiville J, Watson M, Massey A, Popescu R, Oates J: A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol. 1997, 8: 995-1001. 10.1023\/A:1008263516099.","journal-title":"Ann Oncol"},{"key":"33_CR22","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1200\/JCO.2003.03.074","volume":"21","author":"I Chau","year":"2003","unstructured":"Chau I, Cunningham D: Oxaliplatin for colorectal cancer in the United States: better late than never. J Clin Oncol. 2003, 21: 2049-2051. 10.1200\/JCO.2003.03.074.","journal-title":"J Clin Oncol"}],"container-title":["BMC Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-6-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6904-6-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-6-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T05:52:30Z","timestamp":1587189150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/1472-6904-6-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1186\/1472-6904-6-5","relation":{},"ISSN":["1472-6904"],"issn-type":[{"value":"1472-6904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,12]]},"article-number":"5"}}